Coronavirus patient in US treated with stethoscope-wielding robot

Michael Walter | | Health Exec | Artificial Intelligence

The first person diagnosed with the deadly Wuhan coronavirus in the United States is receiving care from a small team of healthcare providers and an advanced robot.

According to CNN, the robot has been using a stethoscope to monitor the patient’s vitals. Its large screen is also being used to improve communication.  

A man diagnosed with Wuhan coronavirus near Seattle is being treated largely by…

The patient, described as a male in his 30s, had recently traveled to Wuhan, China, where the disease originated. He arrived at Seattle-Tacoma International Airport on Jan. 15, quickly realizing he was experiencing symptoms associated with coronavirus.

After arriving at the hospital in “a special isolated gurney called an ISOPOD,” the patient was placed in a quiet area for treatment. It is still unknown when he may be released, but the CDC has officially recommended additional testing.

Click below for the full story from CNN:

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

5 ways AI can help make healthcare more affordable for everyone
HIMSS survey report: Beware insider threats to cybersecurity involving AI
Cleerly and Bunkerhill Health unite in the name of AI-based cardiac imaging evaluations
Academic health system working on AI dictation feature for Epic
Primary care is primed for AI. But is AI aligned with primary care?
5 steps for evaluating radiology AI applications

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.